Literature DB >> 28713004

Results of a prospective randomized control trial comparing hydrophilic to uncoated catheters in children with neurogenic bladder.

William DeFoor1, Pramod Reddy2, Melissa Reed3, Brian VanderBrink2, Elizabeth Jackson2, Bin Zhang4, Julie Denlinger3, Paul Noh2, Eugene Minevich2, Curtis Sheldon2.   

Abstract

INTRODUCTION: Children with neurogenic bladder (NGB) often require a lifetime of clean intermittent catheterization (CIC), typically using uncoated catheters (UCs). Hydrophilic catheters (HCs) have lower friction than UCs with reported less damage to the urethra. The purpose of this study is to compare outcomes between these catheters.
METHODS: An investigator-initiated, prospective, randomized clinical trial was conducted to compare HCs versus UCs. Children aged 2-17 years with NGB on CIC were enrolled for 1 year. Block randomization was used. Dexterity scores were obtained in those who perform self-catheterization. Outcomes were UTI, difficulty passing the catheter, urethral injury, and patient satisfaction.
RESULTS: Demographic data is presented in the Table. Seventy-eight patients were enrolled. Age and gender were similar between the groups. Fifteen patients in each group performed CIC via an abdominal wall stoma. Eight and 15 patients withdrew from the UC and HC groups, respectively. The HC group overall had more problems with the catheter, mainly difficulty with handling. There were no differences for passing the catheter, pain, hematuria, or urethral injuries. There were two urinary tract infections (UTIs) in two HC patients and 17 UTIs in seven UC patients (p = 0.003). Patients with UTIs in the HC group went from 16% in the previous year to 5% during the study. Three children in the HC group had three or more UTIs in the year before enrollment and none during the study. The patients that completed the study with HC were overall satisfied and many requested to continue with the HC.
CONCLUSIONS: HCs may decrease the risk of UTI in children with NGB. Urethral complications were low in both groups. Most HC patients were pleased but some found the slippery coating difficult to handle.
Copyright © 2017 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hydrophilic catheter; Neurogenic bladder; Urinary tract infection

Mesh:

Year:  2017        PMID: 28713004     DOI: 10.1016/j.jpurol.2017.06.003

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  6 in total

Review 1.  Intermittent catheter techniques, strategies and designs for managing long-term bladder conditions.

Authors:  Jacqui A Prieto; Catherine L Murphy; Fiona Stewart; Mandy Fader
Journal:  Cochrane Database Syst Rev       Date:  2021-10-26

Review 2.  The evidence supporting single-use intermittent catheters in people with spinal cord injury.

Authors:  Peter Wayne New
Journal:  Spinal Cord Ser Cases       Date:  2020-09-30

3.  Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

Review 4.  Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida.

Authors:  Michael Tradewell; Joseph J Pariser; Tony Nimeh; Sean P Elliott
Journal:  Transl Androl Urol       Date:  2018-05

Review 5.  Effects of hydrophilic coated catheters on urethral trauma, microtrauma and adverse events with intermittent catheterization in patients with bladder dysfunction: a systematic review and meta-analysis.

Authors:  Xi Liao; Yuwei Liu; Shiqi Liang; Ka Li
Journal:  Int Urol Nephrol       Date:  2022-04-21       Impact factor: 2.266

Review 6.  A scoping review on the impact of hydrophilic versus non-hydrophilic intermittent catheters on UTI, QoL, satisfaction, preference, and other outcomes in neurogenic and non-neurogenic patients suffering from urinary retention.

Authors:  Kim Bundvig Barken; Rikke Vaabengaard
Journal:  BMC Urol       Date:  2022-09-19       Impact factor: 2.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.